tiprankstipranks
Trending News
More News >
Monogram Orthopaedics Inc (MGRM)
:MGRM
US Market
Advertisement

Monogram Orthopaedics Inc (MGRM) Price & Analysis

Compare
109 Followers

MGRM Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.80%2.53%<0.01%93.83%
<0.01% Other Institutional Investors
93.83% Public Companies and
Individual Investors

MGRM FAQ

What was Monogram Orthopaedics Inc’s price range in the past 12 months?
Monogram Orthopaedics Inc lowest stock price was $1.92 and its highest was $6.02 in the past 12 months.
    What is Monogram Orthopaedics Inc’s market cap?
    Currently, no data Available
    When is Monogram Orthopaedics Inc’s upcoming earnings report date?
    Monogram Orthopaedics Inc’s upcoming earnings report date is Aug 13, 2025 which is in 17 days.
      How were Monogram Orthopaedics Inc’s earnings last quarter?
      Monogram Orthopaedics Inc released its earnings results on May 14, 2025. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.115 by $0.015.
        Is Monogram Orthopaedics Inc overvalued?
        According to Wall Street analysts Monogram Orthopaedics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Monogram Orthopaedics Inc pay dividends?
          Monogram Orthopaedics Inc does not currently pay dividends.
          What is Monogram Orthopaedics Inc’s EPS estimate?
          Monogram Orthopaedics Inc’s EPS estimate is -0.09.
            How many shares outstanding does Monogram Orthopaedics Inc have?
            Monogram Orthopaedics Inc has 36,159,576 shares outstanding.
              What happened to Monogram Orthopaedics Inc’s price movement after its last earnings report?
              Monogram Orthopaedics Inc reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.115. Following the earnings report the stock price went up 8.8%.
                Which hedge fund is a major shareholder of Monogram Orthopaedics Inc?
                Currently, no hedge funds are holding shares in MGRM

                Company Description

                Monogram Orthopaedics Inc

                Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

                MGRM Earnings Call

                Q1 2025
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                The earnings call highlighted significant achievements such as FDA clearance and a strong financial position, alongside strategic clinical trial approvals. However, there are challenges related to the slow rollout, capital needs, and competition from established players. The sentiment is slightly positive due to the weight of key achievements.Read More>
                Similar Stocks
                Company
                Price & Change
                Follow
                Orthofix
                Xtant Medical Holdings
                OrthoPediatrics
                Bone Biologics
                Tenon Medical, Inc.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis